Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 x 106/l

AIDS

Volumn 11, Issue 1, 1997, Pages 53-57

  García, Felipe ^a   Vidal, Carmen ^a   Gatell, José M ^a,b   Miró, Joś M ^a   Soriano, Alex ^a   Pumarola, Tomás ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Asymptomatic patients; CD4+ cells 500 x 106 l; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS TITRATION;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; RNA, VIRAL; VIRAL LOAD; VIREMIA;

EID: 0031016048     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199701000-00008     Document Type: Article

References (18)

1. Saksela K, Stevens CE, Rubinstein P, Taylor PE, Baltimore D: HIV-1 messenger RNA in peripheral blood mononuclear cells as an early marker of risk for progression to AIDS. Ann Intern Med 1995, 123:641-640.
2. Verhofstede C, Reniers S, Van Wanzeele F, Plum J: Evaluation of proviral copy number and plasma RNA level as early indicators of progression in HIV-1 infection: correlation with virological and immunological markers of disease. AIDS 1994, 8:1421-1427.
3. Ioannidis JPA, Cappelleri JC, Lau J, Sacks HS, Skolnik PR: Predictive value of viral load measurements in asymptomatic untreated HIV-1 infection: a mathematical model. AIDS 1996, 10:255-262.
4. Ho DD: Viral counts count in HIV infection. Science 1996, 272:1124-1125.
5. Katzenstein TL, Pedersen C, Nielsen C, Lundgren JD, Jakobsen PH, Gerstoft J: Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical out-come. AIDS 1996, 10:167-173.
6. Volverding PA: HIV quantification: clinical applications. Lancet 1996, 347:71-73.
7. O'Brien WA, Hartigan PM, Martin D, et al.: Changes in plasma HIV-1 RNA and CD4 lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996, 334:426-431.
8. Mellors JW, Kingsley LA, Rinaldo CR, et al.: Quantification of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995, 122:573-579.
9. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167-1170.
10. Carpenter CCJ, Fischl MA, Hammer SM, et al.: Antiretroviral therapy for HIV infection in 1996 JAMA 1996, 276:146-154.
11. Holodniy M, Mole L, Winters M, Merigan TC: Diurnal and short-term stability of viral load as measured by gene amplification. J Acquit Immune Defic Syndr 1994, 7:363-368.
12. Cao Y, Ho DD, Todd J, et al.: Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Hum Retrovirus 1995, 11:335-361.
13. Lin HJ, Myers E, Yen-Lieberman B, et al.: Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. ; Infect Dis 1994, 170:553-562.
14. Staprans SI, Hamilton BL, Follansbee SE, et. al.: Activation of virus replication after vaccination of HIV-1 infected individuals. J Exp Med 1995, 182:1727-1737.
15. O'Brien WA, Grovit-Ferbas K, Namazi A, et al.: Human immunodeficiency virus-type 1 replication can be increases in peripheral blood of seropositive patient; after influenza vaccination. Blood 1995, 86:1082-1089.
16. Saag MS, Holodniy M, Kuritzkes DR, et al.: HIV viral load markers in clinical practice. Nature Med 1996, 2:625-629.
17. Keet IPM, Krijnen P, Koot M, et al.: Prediclors of rapid progression to AIDS in HIV-1 seroconverters. AIDS 1993, 7:51-57.
18. Sinicco A, Fora R, Sciandra M, Lucchini A, Caramello P, Giovanni P: Risk of developing AIDS after primary acute HIV-1 infection. J Acquir Immune Defic Syndr 1993, 6:575-581.